Clinical Trial Update: Study to Evaluate the Efficacy of Axicabtagene Ciloleucel in Patients With Late Relapse of Diffuse Large B-Cell Lymphoma [Phase 2]

View source ↗

Summary

This Phase 2 trial is evaluating the efficacy of axicabtagene ciloleucel in patients with late-relapse diffuse large B-cell lymphoma and is currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Axicabtagene ciloleucel (Yescarta) (axicabtagene ciloleucel)

Snippet

Sponsor: Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea | Conditions: DIFFUSE LARGE B-CELL LYMPHOMA | Phase 2 | Status: RECRUITING